Kane Logo Cropped TransBG.png
Kane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel Spray
January 31, 2024 08:30 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that it has filed a patent on its revyve™...
Kane Logo Cropped TransBG.png
Kane Biotech to Present its revyve™ Antimicrobial Wound Gel at Boswick Burn and Wound Care Symposium
January 25, 2024 12:03 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) today announces that the Company will be presenting its...
Kane Logo Cropped TransBG.png
Kane Biotech to Release Third Quarter 2023 Financial Results on November 28, 2023 – Conference Call to Follow
November 21, 2023 07:45 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Logo Cropped TransBG.png
Kane Biotech Strengthens Board with Biotech Executive
November 16, 2023 13:45 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) is pleased to announce that John Coleman has been...
Arch_Twitter_Logo.png
Arch Therapeutics Provides Year End Operational Update
November 09, 2023 06:50 ET | Arch Therapeutics, Inc.
Fiscal year-end AC5 Advanced Wound System update includes Q4 record monthly order volumes, favorable reimbursement decisions and increases in paid claims.
3239-KAN-Revyve_Box&Tube_LG-d2-FL
Kane Biotech and ProgenaCare Global Launch Newly Rebranded revyve™ Antimicrobial Wound Gel at Advanced Wound Care Fall Forum
November 02, 2023 11:48 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) in partnership with ProgenaCare Global LLP (“ProgenaCare”) today...
cmi_logo.png
[Latest] Global Biofilms Treatment Market Size/Share Worth USD 3.5 Billion by 2032 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
September 05, 2023 16:30 ET | Custom Market Insights
Austin, TX, USA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Biofilms Treatment Market Size, Trends and Insights By Product (Debridement...
TIP_link_300x300.jpg
$4.50Bn Growth for Surgical Sutures Market to Hit 5.4% CAGR, Globally, by 2025 – Premium Report by The Insight Partners
June 27, 2023 14:06 ET | The Insight Partners
Pune, India, June 27, 2023 (GLOBE NEWSWIRE) -- According to our latest study on "Surgical Sutures Market Size Report, Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, and...
Kane Logo Cropped TransBG.png
Kane Biotech Announces First Quarter 2023 Financial Results
May 25, 2023 16:05 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, May 25, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
coactiv wound gel
Kane Biotech Announces FDA 510(k) Clearance for its coactiv+™ Antimicrobial Wound Gel
May 25, 2023 10:38 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, May 25, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces that on May 24, 2023 it received 510(k) clearance of its...